Skip to main content
Top

Familial Cancer

Issue 2/2015

Content (17 Articles)

Original Article

Desmoid tumors: clinical features and outcome of an unpredictable and challenging manifestation of familial adenomatous polyposis

Fábio Guilherme Campos, Carlos Augusto Real Martinez, Marleny Novaes, Sérgio Carlos Nahas, Ivan Cecconello

Original Article

Comparison of proctocolectomy and ileal pouch-anal anastomosis to colectomy and ileorectal anastomosis in familial adenomatous polyposis

L. Koskenvuo, H. Mustonen, L. Renkonen-Sinisalo, H. J. Järvinen, A. Lepistö

Original Article

A risk of digestive tract neoplasms susceptibility in miR-146a and miR-196a2

Mingkun Xie, Yating Li, Jing Wu, Jin Wu

Original Article

Exome sequencing reveals three novel candidate predisposition genes for diffuse gastric cancer

Iikki Donner, Tuula Kiviluoto, Ari Ristimäki, Lauri A. Aaltonen, Pia Vahteristo

Open Access Original Article

High-resolution melting (HRM) re-analysis of a polyposis patients cohort reveals previously undetected heterozygous and mosaic APC gene mutations

Astrid A. Out, Ivonne J. H. M. van Minderhout, Nienke van der Stoep, Lysette S. R. van Bommel, Irma Kluijt, Cora Aalfs, Marsha Voorendt, Rolf H. A. M. Vossen, Maartje Nielsen, Hans F. A. Vasen, Hans Morreau, Peter Devilee, Carli M. J. Tops, Frederik J. Hes

Original Article

Defective DNA mismatch repair activity is common in sebaceous neoplasms, and may be an ineffective approach to screen for Lynch syndrome

Anu R. Lamba, Angela Y. Moore, Todd Moore, Jennifer Rhees, Mildred A. Arnold, C. Richard Boland

Original Article

Health professionals’ evaluation of delivering treatment-focused genetic testing to women newly diagnosed with breast cancer

Kirsten F. L. Douma, Bettina Meiser, Judy Kirk, Gillian Mitchell, Christobel Saunders, Belinda Rahman, Mariana S. Sousa, Kristine Barlow-Stewart, Margaret Gleeson, Kathy Tucker

Original Article

Impact of BRCA1/2 mutation on young women’s 5-year parenthood rates: a prospective comparative study (GENEPSO-PS cohort)

Julien Mancini, Emmanuelle Mouret-Fourme, Catherine Noguès, Claire Julian-Reynier

Short Communication

The effect of oral 3,3′-diindolylmethane supplementation on the 2:16α-OHE ratio in BRCA1 mutation carriers

Dina Nikitina, Marcia Llacuachaqui, Daniel Sepkovic, H. Leon Bradlow, Steven A. Narod, Joanne Kotsopoulos

Original Article

Large genomic rearrangements in the familial breast and ovarian cancer gene BRCA1 are associated with an increased frequency of high risk features

Paul A. James, Sarah Sawyer, Samantha Boyle, Mary-Anne Young, Serguei Kovalenko, Rebecca Doherty, Joanne McKinley, Kathryn Alsop, Victoria Beshay, Marion Harris, Stephen Fox, Geoffrey J. Lindeman, Gillian Mitchell

Original Article

Mutations of HNRNPA0 and WIF1 predispose members of a large family to multiple cancers

Chongjuan Wei, Bo Peng, Younghun Han, Wei V. Chen, Joshua Rother, Gail E. Tomlinson, C. Richard Boland, Marc Chaussabel, Marsha L. Frazier, Christopher I. Amos

Erratum

Erratum to: Mutations of HNRNPA0 and WIF1 predispose members of a large family to multiple cancers

Chongjuan Wei, Bo Peng, Younghun Han, Wei V. Chen, Joshua Rother, Gail E. Tomlinson, C. Richard Boland, Damien Chaussabel, Marsha L. Frazier, Christopher I. Amos

Original Article

First-Line sunitinib in patients with renal cell carcinoma (RCC) in von Hippel–Lindau (VHL) disease: clinical outcome and patterns of radiological response

Anna Roma, Marco Maruzzo, Umberto Basso, Antonella Brunello, Rita Zamarchi, Elisabetta Bezzon, Fabio Pomerri, Stefania Zovato, Giuseppe Opocher, Vittorina Zagonel

Original Article

Parental age and Neurofibromatosis Type 1: a report from the NF1 Patient Registry Initiative

Qian Liu, Nancy Zoellner, David H. Gutmann, Kimberly J. Johnson

Review Article

The roles of AXIN2 in tumorigenesis and epigenetic regulation

Shuang Li, Chunpeng Wang, Xiaodong Liu, Shucheng Hua, Xin Liu

Short Communication

The breast cancer immunophenotype of TP53-p.R337H carriers is different from that observed among other pathogenic TP53 mutation carriers

Mariana Fitarelli-Kiehl, Juliana Giacomazzi, Patricia Santos-Silva, Marcia Silveira Graudenz, Edenir Inez Palmero, Rodrigo Augusto Depieri Michelli, Maria Isabel Achatz, Cynthia Aparecida Bueno de Toledo Osório, Victor Evangelista de Faria Ferraz, Clarissa Gondim Picanço, Patricia Ashton-Prolla

Original Article

Germline RAD51B truncating mutation in a family with cutaneous melanoma

Karin A. W. Wadt, Lauren G. Aoude, Lisa Golmard, Thomas V. O. Hansen, Xavier Sastre-Garau, Nicholas K. Hayward, Anne-Marie Gerdes

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine